Details for New Drug Application (NDA): 021551
✉ Email this page to a colleague
The generic ingredient in HALFLYTELY is bisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the bisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride profile page.
Summary for 021551
Tradename: | HALFLYTELY |
Applicant: | Braintree |
Ingredient: | bisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride |
Patents: | 0 |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SOLUTION, TABLET, DELAYED RELEASE;ORAL | Strength | 5MG,N/A;N/A,210GM;N/A,0.74GM;N/A,2.86GM;N/A,5.6GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Jul 16, 2010 | TE: | RLD: | Yes |
Expired US Patents for NDA 021551
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Braintree | HALFLYTELY | bisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride | FOR SOLUTION, TABLET, DELAYED RELEASE;ORAL | 021551-003 | Jul 16, 2010 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription